Literature DB >> 10458762

Regulation of cell survival during B lymphopoiesis: suppressed apoptosis of pro-B cells in P53-deficient mouse bone marrow.

L Lu1, D Lejtenyi, D G Osmond.   

Abstract

B cell development in mouse bone marrow (BM) is subject to quality controls that eliminate aberrant cells by apoptosis, but the intrinsic cellular mechanisms that mediate this negative B cell selection remain unclear. The p53 tumor suppressor transduces signals resulting in apoptosis and cell cycle arrest in cells that sustain DNA damage. Faulty V(D)J recombination in scid lymphocyte precursors activates a p53-dependent DNA damage checkpoint. In the present study, we have examined whether p53 is involved in apoptotic selection of normally developing B cells in BM. Double immunofluorescence labeling and flow cytometry were used to quantitate phenotypically defined B cell populations and their apoptotic rates in BM of homozygous p53-deficient mice. B220(+) mu(-) and terminal deoxynucleotidyl transferase (TdT)(+) pro-B cells were increased in both incidence and absolute number to controls. In contrast, pre-B cells were only slightly increased and the sIgM(+) B lymphocyte compartment remained essentially normal. The incidence of apoptosis among p53(-/-) pro-B cells was greatly reduced, both ex vivo and in short-term culture, whereas, apoptosis of pre-B cells and B lymphocytes was not significantly different from normal. The results indicate that p53 is actively involved as an apoptosis inducer at an early quality control checkpoint in B lymphopoiesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10458762     DOI: 10.1002/(SICI)1521-4141(199908)29:08<2484::AID-IMMU2484>3.0.CO;2-B

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Miz-1 regulates translation of Trp53 via ribosomal protein L22 in cells undergoing V(D)J recombination.

Authors:  Marissa Rashkovan; Charles Vadnais; Julie Ross; Mathieu Gigoux; Woong-Kyung Suh; Wei Gu; Christian Kosan; Tarik Möröy
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-02       Impact factor: 11.205

2.  Rpl22 Loss Impairs the Development of B Lymphocytes by Activating a p53-Dependent Checkpoint.

Authors:  Shawn P Fahl; Bryan Harris; Francis Coffey; David L Wiest
Journal:  J Immunol       Date:  2015-01-01       Impact factor: 5.422

3.  Phosphatase Wip1 controls antigen-independent B-cell development in a p53-dependent manner.

Authors:  Weiwei Yi; Xuelian Hu; Zhiyang Chen; Leiming Liu; Yuan Tian; Hui Chen; Yu-Sheng Cong; Fan Yang; Lianfeng Zhang; Karl Lenhard Rudolph; Zhixin Zhang; Yong Zhao; Zhenyu Ju
Journal:  Blood       Date:  2015-05-26       Impact factor: 22.113

4.  Msh2-dependent DNA repair mitigates a unique susceptibility of B cell progenitors to c-Myc-induced lymphomas.

Authors:  Rajeev M Nepal; Li Tong; Blerta Kolaj; Winfried Edelmann; Alberto Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-16       Impact factor: 11.205

5.  Novel INHAT repressor (NIR) is required for early lymphocyte development.

Authors:  Chi A Ma; Antonia Pusso; Liming Wu; Yongge Zhao; Victoria Hoffmann; Luigi D Notarangelo; B J Fowlkes; Ashish Jain
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-08       Impact factor: 11.205

Review 6.  Phosphatase Wip1 in Immunity: An Overview and Update.

Authors:  Xiao-Fei Shen; Yang Zhao; Jin-Peng Jiang; Wen-Xian Guan; Jun-Feng Du
Journal:  Front Immunol       Date:  2017-01-17       Impact factor: 7.561

7.  Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification.

Authors:  Michael J Difilippantonio; Simone Petersen; Hua Tang Chen; Roger Johnson; Maria Jasin; Roland Kanaar; Thomas Ried; André Nussenzweig
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

8.  CNOT3 contributes to early B cell development by controlling Igh rearrangement and p53 mRNA stability.

Authors:  Takeshi Inoue; Masahiro Morita; Atsushi Hijikata; Yoko Fukuda-Yuzawa; Shungo Adachi; Kyoichi Isono; Tomokatsu Ikawa; Hiroshi Kawamoto; Haruhiko Koseki; Tohru Natsume; Taro Fukao; Osamu Ohara; Tadashi Yamamoto; Tomohiro Kurosaki
Journal:  J Exp Med       Date:  2015-08-03       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.